(Total Views: 69)
Posted On: 09/10/2025 1:55:46 PM
Post# of 25912

CEL-SCI $CVM #NYSE Accelerates Global Expansion with Strategic Partnership Exciting news for #biotech! CEL-SCI has partnered with Dallah Pharma in Saudi Arabia to advance Multikine, a groundbreaking immunotherapy for #cancer treatment. This move marks a significant step in bringing innovative solutions to patients worldwide.
???? Learn more: https://biotechhealthx.com/biotech-news/saudi...ikine-now/
???? Learn more: https://biotechhealthx.com/biotech-news/saudi...ikine-now/

